29-09-2026
Launching InviDx®
Rapid detection of bacteria and resistance genes across human health, veterinary, food and environmental applications!
InviDx® brings molecular detection closer to the sample, combining a compact instrument, dedicated assays and automated result interpretation through the InviDx® Hub. Combined with the InviScreen® UTI Pathogen Panel and InviScreen® AMR Gene Panel, it enables targeted detection of clinically relevant bacteria and selected antimicrobial resistance genes across human, animal, food, and environmental sample types.
It launches with 2 panels:
InviScreen® UTI Pathogen Panel
Detects 10 UTI-associated microorganisms from urine, with results in under 60 minutes.
InviScreen® AMR Gene Panel
Screens for antimicrobial resistance genes, bringing faster AMR insight closer to where surveillance happens.
One platform. One Health.
From pathogen detection to AMR surveillance, InviDx® was built to make decentralised molecular testing possible across different settings.
For more information, contact Sales & Portfolio Manager Charlotte Otéma.